Replies to post #56647 on Ariad Pharmaceuticals Inc fka ARIA

[Jesspro]

Let's not revisit the ghost of the past. Let's move on. I have a little irrational exuberance on my part this time because of how the news about ponatinib/Iclusig, 113 and Nmole are unfolding in our very eyes. Where as before it was just CML. Right now the evolving treatment of CML by Iclusig is something to look forward to. ASH will tell the story.